Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea · Delayed Price · Currency is KRW 415,000
+26,500 (6.82%)
Oct 30, 2026, 3:30 PM KST
Hanmi Pharm. Market Cap
Hanmi Pharm. has a market cap or net worth of 5.27 trillion as of October 30, 2026. It is the 4,319th most valuable company in the world and the 94th biggest in South Korea. Its market cap has increased by 5.54% in one year.
Market Cap
5.27T
Enterprise Value
5.46T
Revenue
1.66T
Global Rank
Country Rank
#94 South Korea
PE Ratio
24.27
ChartMarket Cap Chart
Since July 30, 2010, Hanmi Pharm.'s market cap has increased from 680.70B to 5.27T, an increase of 673.61%. That is a compound annual growth rate of 13.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 5.27T | -8.12% |
| Dec 30, 2025 | 5.73T | 61.14% |
| Dec 30, 2024 | 3.56T | -20.49% |
| Dec 28, 2023 | 4.47T | 20.54% |
| Dec 29, 2022 | 3.71T | 10.00% |
| Dec 30, 2021 | 3.37T | -23.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Yuhan | 5.57T |
| Hanall Biopharma | 1.92T |
| Celltrion Pharm | 1.63T |
| GC Biopharma | 1.51T |
| Daewoong Pharmaceutical | 1.17T |
| Chong Kun Dang Pharmaceutical | 823.50B |
| Boryung | 700.77B |
| Daewoong | 626.35B |